These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Medicare and Medicaid programs, less than effective drugs: Health Care Financing Administration. Notice of legislation affecting implementation and enforcement of interim final rule. Fed Regist; 1982 Apr; 47(74):16339. PubMed ID: 10298508 [TBL] [Abstract][Full Text] [Related]
23. Suppliers. A whole new market. Becker C Mod Healthc; 2005 Feb; 35(9):18. PubMed ID: 15771052 [No Abstract] [Full Text] [Related]
24. [Changes of drug reimbursement expenses incurred by National Health Fund in Silesian voivodeship in the period of 1999-2004]. Swistak P; Dzielicki M; Janiec R; Błońska-Fajfrowska B Wiad Lek; 2005; 58(9-10):495-9. PubMed ID: 16529058 [TBL] [Abstract][Full Text] [Related]
26. The quandary of compounding for MCOs: administrative costs, risks, and waste. Kaye T Manag Care; 2003 Jan; 12(1):42-8. PubMed ID: 12575510 [TBL] [Abstract][Full Text] [Related]
27. Managing injectable drugs: an evolving challenge for pharmacy benefit managers. Giaquinta D Manag Care Interface; 2002 Dec; 15(12):15-6. PubMed ID: 12530291 [No Abstract] [Full Text] [Related]
28. Biotechnology and managed care: are they compatible? Dasher T Am Pharm; 1995 Feb; NS35(2):9-10. PubMed ID: 7900654 [No Abstract] [Full Text] [Related]
30. The pitfalls and potential of pharmacy risk. Lawrence J Manag Care; 1998 May; 7(5):45-6, 51-2. PubMed ID: 10180140 [No Abstract] [Full Text] [Related]
31. The focus on true value in the health care system. Giaquinta D Manag Care Interface; 2007 Apr; 20(4):40-1. PubMed ID: 17474329 [No Abstract] [Full Text] [Related]
32. Redistribution of risk throughout the pharmaceutical industry. Scheur BS Med Interface; 1994 Oct; 7(10):77-80. PubMed ID: 10137569 [TBL] [Abstract][Full Text] [Related]
33. Four core strategies used to manage outpatient specialty pharmacy costs. Manag Care; 2006 Dec; 15(12):53. PubMed ID: 17260846 [No Abstract] [Full Text] [Related]
34. A decade of economic challenges to pharmacy. Paul SH Med Mark Media; 1981 Nov; 16(11):31-2, 34-6. PubMed ID: 10253532 [No Abstract] [Full Text] [Related]
35. The effects of managed care on the retail distribution of pharmaceuticals. Carroll NV Manag Care Interface; 1998 Nov; 11(11):105-8, 111-3. PubMed ID: 10187415 [TBL] [Abstract][Full Text] [Related]
36. Sorting out contradictions within managed care. Navarro RP Med Interface; 1996 Sep; 9(9):85-6. PubMed ID: 10161524 [No Abstract] [Full Text] [Related]
37. Managed care changes everything. Navarro RP Med Interface; 1997 Mar; 10(3):87-8. PubMed ID: 10166042 [No Abstract] [Full Text] [Related]
38. The need for pharmacoeconomic studies of pharmacy services. Rascati KL; Moczygemba LR Clin Ther; 2007 Jul; 29(7):1488-90. PubMed ID: 17825700 [No Abstract] [Full Text] [Related]
39. Managed care organizations: an introduction--Part II of II. Vogenberg FR Hosp Pharm; 1995 Feb; 30(2):138, 140-2. PubMed ID: 10184282 [No Abstract] [Full Text] [Related]
40. Mass customization--the next generation of pharmacy management. Chao S Am J Manag Care; 2003 Sep; Suppl Decison Maker News():5-7. PubMed ID: 14567452 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]